UNICA IRIS Institutional Research Information System

FRAU, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 71.523
NA - Nord America 2.373
AS - Asia 273
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 4
OC - Oceania 2
SA - Sud America 2
Totale 74.183
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 70.873
US - Stati Uniti d'America 2.358
UA - Ucraina 254
CN - Cina 227
SE - Svezia 183
FI - Finlandia 59
DE - Germania 56
GB - Regno Unito 55
IN - India 16
VN - Vietnam 16
CA - Canada 14
FR - Francia 11
BE - Belgio 8
RU - Federazione Russa 7
CZ - Repubblica Ceca 6
EU - Europa 6
HK - Hong Kong 5
EG - Egitto 4
SG - Singapore 4
KR - Corea 3
PL - Polonia 3
RO - Romania 3
JP - Giappone 2
NL - Olanda 2
AU - Australia 1
BR - Brasile 1
CH - Svizzera 1
CL - Cile 1
IE - Irlanda 1
LU - Lussemburgo 1
MX - Messico 1
NZ - Nuova Zelanda 1
Totale 74.183
Salva come PNG Salva come JPEG
Città #
Cagliari 70.743
Woodbridge 294
Fairfield 287
Chandler 264
Ann Arbor 143
Jacksonville 137
Nyköping 136
Ashburn 131
Houston 130
Seattle 123
Wilmington 117
Dearborn 101
Cambridge 97
New York 60
Nanjing 40
Boardman 37
Beijing 30
Boston 29
Shanghai 26
Helsinki 23
Shenyang 20
Redwood City 19
Milan 18
San Diego 18
Los Angeles 17
Dong Ket 16
Hebei 13
Jinan 13
Norwalk 12
Guangzhou 11
Jiaxing 10
Mountain View 10
Toronto 10
Changsha 9
Nanchang 9
Brussels 8
Orange 8
Verona 7
London 6
Ningbo 6
Oristano 6
Padova 6
Tianjin 6
Modrice 5
Pune 5
Zhengzhou 5
Chengdu 4
Gurgaon 4
Hangzhou 4
Hong Kong 4
Kunming 4
Rome 4
Sassari 4
Auburn Hills 3
Baveno 3
Cracow 3
Hefei 3
Millbury 3
Monopoli 3
Phoenix 3
Saint Petersburg 3
San Jose 3
San Mateo 3
Sestu 3
Washington 3
Assèmini 2
Atlanta 2
Augusta 2
Cedar Knolls 2
Chicago 2
Council Bluffs 2
Escolca 2
Falls Church 2
Fuzhou 2
Gonnosfanadiga 2
Indiana 2
Indianapolis 2
Jinhua 2
Palo Alto 2
Prescot 2
Redmond 2
Salerno 2
Stockholm 2
Suceava 2
Tappahannock 2
Wuhan 2
Aci Catena 1
Acton 1
Amsterdam 1
Auckland 1
Bar Harbor 1
Boiling Springs 1
Borås 1
Central 1
Chiswick 1
Claremont 1
Dundalk 1
Dübendorf 1
Evanston 1
Focsani 1
Totale 73.341
Salva come PNG Salva come JPEG
Nome #
Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. 2.958
PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests nigrostriatal degeneration in a progressive Parkinson’s disease model. 2.886
Antagonism of Adenosine A1 or A2A Receptors Amplifies the Effects of 3,4-Methylendioxymethamphetamine (MDMA) on Glial Activation in the Mouse Brain: Relevance to Caffeine-MDMA Interactions 2.823
A442 PPAR-gamma agonist rosiglitazone inhibits TNF-alpha production by microglia and arrests neurodegeneration in a progressive Parkinson´s disease model 2.704
Protective Agents in Parkinson's Disease: Caffeine and Adenosine A2A Receptor Antagonists 2.683
Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: Implications for the study of the affective properties of drugs of abuse 2.553
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice 2.466
Symptomatic and Neuroprotective Effects of A2A Receptor Antagonists in Parkinson’s Disease 2.413
MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice 2.412
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 2.343
Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain 2.337
Influence of caffeine on 3,4-methylenedioxymethamphetamine-induced dopaminergic neuron degeneration and neuroinflammation is age-dependent 2.331
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility 2.310
Widespread reduction of dopamine cell bodies and terminals in adult rats exposed to a low dose regimen of MDMA during adolescence 2.256
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.147
Progressive Dopaminergic Degeneration in the Chronic MPTPp Mouse Model of Parkinson's Disease 2.143
Contribution of Caffeine to the Psychostimulant, Neuroinflammatory and Neurotoxic Effects of Amphetamine-Related Drugs 1.999
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease 1.960
Caffeine Enhances Astroglia and Microglia Reactivity Induced by 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) in Mouse Brain 1.938
Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons 1.918
Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression 1.872
Role of movement in long-term basal ganglia changes: implications for abnormal motor responses 1.781
PPAR-GAMMA RECEPTOR AGONIST PREVENTS NEURODEGENERATION AND BEHAVIOURAL DEFICITS IN A CHRONIC MPTP MOUSE MODEL OF PARKINSON’S DISEASE. 1.752
Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? 1.686
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.659
null 1.651
PROGRESSIVE DECLINE OF BEHAVIORAL AND BIOCHEMICAL PARAMETERS IN THE CHRONIC MPTP/PROBENECID MOUSE MODEL OF PARKINSON’S DISEASE. 1.632
PEROXIZOME-PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARG) AGONIST ROSIGLITAZONE COUNTERACTS BEHAVIORAL AND BIOCHEMICAL DEFICITS IN A CHRONIC 1-METHYL-4-PHENIL-1,2,3,4 TETRAHYDROPYRIDINE (MPTP) MOUSE MODEL OF PARKINSON’S DISEASE 1.575
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.539
Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. 1.464
Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat 1.410
Effect of caffeine on 3,4- methylenedioxymethamphetamine-induced neuroinflammation in mouse brain 1.160
Effect of caffeine on 3, 4 – methylenedioxymethamphetamine – induced astroglia and microglia activation in mouse brain 1.118
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats 1.105
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.036
Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence 1.023
null 981
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 929
Protective Agents in Parkinson’s Disease: Caffeine and Adenosine A2A Receptor Antagonists 593
Behavioural and biochemical correlates of high and low dyskinetic parkinsonian drugs 517
Behavioural correlates of dopaminergic agonists dyskinetic potential in the 6-OHDA lesioned rat 165
Modulatory role of adenosine A(2A) receptors in basal ganglia as basis for the use of A(2A) antagonists in the treatment of Parkinson's disease 111
Totale 74.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.499
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.499
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019604 0 0 0 0 0 0 0 0 0 0 325 279
2019/202016.267 792 490 101 219 6.420 4.126 2.241 438 280 392 267 501
2020/202118.608 610 703 897 6.131 3.938 1.682 1.394 875 356 692 741 589
2021/20223.751 333 284 320 195 175 273 388 277 220 327 355 604
2022/20236.193 733 1.043 648 465 559 542 292 340 399 419 526 227
2023/20244.518 280 370 195 305 541 849 831 336 236 374 201 0
Totale 74.339